Haier Biomedical Showcases Cutting-Edge Laboratory Solutions at analytica Munich 2026

Haier Biomedical Spotlights Full-Scenario Lab Solutions at analytica Munich 2026



On April 10, 2026, Haier Biomedical, a frontrunner in life sciences and medical solutions, made waves at the analytica Munich 2026 exhibition. The event highlighted the company's commitment to providing complete laboratory solutions tailored for European markets under the theme "In Europe, for Europe."

A Shift in Strategy


Haier Biomedical is transitioning from being a traditional equipment supplier to a comprehensive laboratory solutions provider. With an emphasis on biobanks, research labs, and pharmacies, the company is dedicated to improving processes from collection to storage, monitoring, and management of samples. This strategic pivot underscores their aim to tackle real-world challenges regarding sample integrity, operational efficiency, and data traceability.

Innovative Offerings


At analytica 2026, Haier Biomedical showcased an extensive portfolio of state-of-the-art equipment designed for the life sciences sector. This included:
  • - CO₂ incubators
  • - Biosafety cabinets
  • - Centrifuges
  • - Pharmacy refrigerators
  • - Liquid nitrogen containers
  • - Autoclaves
  • - The newly launched Incubator Shakers, specifically engineered for continuous oscillation and precise temperature control, ideal for cell suspension cultures.

Additionally, they introduced the UltraEco ULT freezer series, equipped with Eco-Drive technology that delivers 30% improved efficiency compared to industry benchmarks. This product line aims to enhance operational productivity while minimizing energy consumption.

Comprehensive Solutions


Haier Biomedical's offerings extend beyond individual products. They are now rolling out fully integrated and automated workflows that streamline the collection, storage, and tracking of biological samples. These advancements represent significant progress in addressing the complexities faced by professionals in life sciences labs around Europe.

Commitment to Local Presence


The company's philosophy of globalization emphasizes deepening its roots in local markets. This "one country, one strategy" approach has led to localized operations in 18 countries globally, resulting in over 400 local product certifications. Remarkably, local teams now make up more than 40% of Haier Biomedical's global workforce. This localized strategy has positioned the company as a market leader among Chinese brands in several countries, including Italy, where they are set to establish a subsidiary to enhance service capabilities for local industry clients.

Noteworthy milestones include the successful end-to-end delivery of custom biosafety cabinets to Queen Mary University in London within a tight 24-hour timeframe, as well as the provision of a smart blood management system, U-Blood, to a local hospital in Italy, integrating intelligent solutions into the European healthcare landscape. Additionally, in Germany, they supplied ultra-low -150°C cryogenic freezers to leading local universities, marrying advanced refrigeration technology with whisper-quiet operation to ensure both safety and efficiency in research settings.

Looking Ahead


analytica 2026 signifies a pivotal moment for Haier Biomedical as the company evolves from merely exporting products to co-creating ecosystems tailored to local needs. Their new operational model, defined as "technology + local presence + ecosystem," lays the groundwork for future growth. Moving forward, Haier Biomedical aims to solidify its footprint in Europe while leveraging local strengths to support global expansion, with a vision to become a trusted name in life sciences for users around the globe.

For more details, visit Haier Biomedical.

Video 1 | Video 2

Topics Consumer Products & Retail)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.